- Home
- COEP vs UONEK Comparison
COEP vs UONEK Comparison
Compare COEP & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- UONEK
- Stock Information
- Founded
- COEP 2017
- UONEK 1980
- Country
- COEP United States
- UONEK United States
- Employees
- COEP N/A
- UONEK N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- UONEK Broadcasting
- Sector
- COEP Health Care
- UONEK Consumer Discretionary
- Exchange
- COEP Nasdaq
- UONEK Nasdaq
- Market Cap
- COEP 27.4M
- UONEK 28.1M
- IPO Year
- COEP N/A
- UONEK N/A
- Fundamental
- Price
- COEP $10.66
- UONEK $0.60
- Analyst Decision
- COEP
- UONEK
- Analyst Count
- COEP 0
- UONEK 0
- Target Price
- COEP N/A
- UONEK N/A
- AVG Volume (30 Days)
- COEP 46.3K
- UONEK 291.4K
- Earning Date
- COEP 08-15-2025
- UONEK 08-07-2025
- Dividend Yield
- COEP N/A
- UONEK N/A
- EPS Growth
- COEP N/A
- UONEK N/A
- EPS
- COEP N/A
- UONEK N/A
- Revenue
- COEP $62,874.00
- UONEK $437,499,000.00
- Revenue This Year
- COEP N/A
- UONEK N/A
- Revenue Next Year
- COEP N/A
- UONEK N/A
- P/E Ratio
- COEP N/A
- UONEK N/A
- Revenue Growth
- COEP N/A
- UONEK N/A
- 52 Week Low
- COEP $2.31
- UONEK $0.44
- 52 Week High
- COEP $13.70
- UONEK $1.57
- Technical
- Relative Strength Index (RSI)
- COEP 65.93
- UONEK 44.08
- Support Level
- COEP $7.25
- UONEK $0.53
- Resistance Level
- COEP $11.70
- UONEK $0.99
- Average True Range (ATR)
- COEP 0.67
- UONEK 0.15
- MACD
- COEP 0.35
- UONEK -0.01
- Stochastic Oscillator
- COEP 76.81
- UONEK 4.93
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.